Sieger Markus - Insider Non-Derivative Transactions at Cyclo Therapeutics, Inc. (CYTH) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 27, 2025, Sieger Markus's relationship to Cyclo Therapeutics, Inc. (CYTH) is Director, and currently has 440,260 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CYTH insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Sieger Markus - Insider Non-Derivative Transactions of CYTH Common Stock

Sieger Markus - Insider Non-Derivative Transactions at CYTH

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 28, 2025	Acquisition -- (Common Stock)	58138	0	440260
Nov 16, 2024	Acquisition -- (Common Stock)	35022	0	382122
Aug 17, 2024	Acquisition -- (Common Stock)	18354	0	347100
Jun 4, 2024	Acquisition -- (Common Stock)	18067	0	328746
Feb 14, 2024	Acquisition -- (Common Stock)	14004	0	310679
Nov 29, 2023	Acquisition -- (Common Stock)	16512	0	296675
Oct 21, 2023	X -- (Common Stock)	59881	0.71	280163
Aug 19, 2023	Acquisition -- (Common Stock)	16269	0	220282
May 18, 2023	Acquisition -- (Common Stock)	42962	0	204013
Apr 21, 2023	P -- (Common Stock)	59881	0.71	161051